Scarica l'app Stockscreener
11.40
1.47%
-0.17
Dopo l'orario di chiusura:
11.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$11.57
Aprire:
$11.69
Volume 24 ore:
3.84M
Relative Volume:
1.08
Capitalizzazione di mercato:
$2.27B
Reddito:
$3.90B
Utile/perdita netta:
$-413.00M
Rapporto P/E:
-5.5072
EPS:
-2.07
Flusso di cassa netto:
$365.00M
1 W Prestazione:
+2.70%
1M Prestazione:
+8.37%
6M Prestazione:
-27.06%
1 anno Prestazione:
-42.19%
Intervallo 1D:
$11.23
$11.75
Intervallo di 1 settimana:
$11.05
$11.79
Portata 52W:
$9.85
$20.59
Dentsply Sirona Inc Stock (XRAY) Company Profile
Nome
Dentsply Sirona Inc
Settore
Industria
Telefono
844-546-3722
Indirizzo
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Confronta XRAY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
11.40 | 2.31B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
559.52 | 192.25B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.09 | 57.34B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.19 | 38.71B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
253.07 | 36.82B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
271.86 | 19.25B | 2.96B | 487.70M | 344.00M | 6.6758 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-11-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Downgrade | Needham | Buy → Hold |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-23 | Downgrade | Jefferies | Buy → Hold |
| 2025-01-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Reiterato | Needham | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-11-16 | Iniziato | Needham | Buy |
| 2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-01 | Ripresa | Credit Suisse | Outperform |
| 2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
| 2021-08-06 | Reiterato | Barrington Research | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
| 2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
| 2020-12-18 | Downgrade | Stifel | Buy → Hold |
| 2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
| 2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
| 2020-06-16 | Iniziato | Piper Sandler | Overweight |
| 2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
| 2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Downgrade | Goldman | Buy → Neutral |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
| 2020-02-19 | Reiterato | Stifel | Buy |
| 2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Iniziato | Evercore ISI | In-line |
| 2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
Dentsply Sirona Inc Borsa (XRAY) Ultime notizie
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Plans $0.16 Quarterly Dividend - MarketBeat
Dentsply Sirona Keeps Quarterly Dividend at $0.16 per Share, Payable Jan. 9 to Holders of Record as of Dec. 26 - marketscreener.com
Dentsply Sirona declares quarterly dividend of $0.16 per share By Investing.com - Investing.com India
Dentsply Sirona declares $0.16 dividend - MSN
Dentsply Sirona Declares Quarterly Cash Dividend - The Manila Times
Glass Ionomer Cement for Dental Market Industry Growth Is Set - openPR.com
Lazard Asset Management LLC Has $160.51 Million Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Engine Capital Management LP - MarketBeat
Armistice Capital LLC Sells 2,498,735 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Director Gregory Lucier Sells 82,200 Shares - MarketBeat
Dentsply Sirona (XRAY): Reassessing Valuation After Michael Pomeroy’s Appointment as Interim CFO - Sahm
Dentsply Sirona Announces Organizational Changes to Simplify Structure, Enhance Profitability, Improve Operational Performance and Drive Growth - ADVFN
RBF Capital LLC Takes $3.18 Million Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Now Covered by Analysts at Barclays - MarketBeat
Mercury-Free Dental Implants Materials Market Is Booming So - openPR.com
Barclays Initiates Coverage of DENTSPLY SIRONA (XRAY) with Underweight Recommendation - Nasdaq
Dentsply Sirona Extends Lease at Hobbs Brook Real Estate’s Waltham Campus Through 2032 - Boston Real Estate Times
Barclays Initiates Coverage on Dentsply Sirona (XRAY) with Under - GuruFocus
U.S. Dental Prosthetics Market Intelligence Report 2025-2033 Featuring Dentsply Sirona, 3D Systems, Solventum, Ivoclar Vivadent, Institut Straumann and MoreResearchAndMarkets.com - Business Wire
DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? - MSN
How Investors Are Reacting To DENTSPLY SIRONA (XRAY) Appointing an Interim CFO With Turnaround Expertise - simplywall.st
Norges Bank Purchases New Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Evaluating the Accuracy of Two Intraoral Scanning Systems in Reproducing Implant Positions for Prosthetic Fabrication: A Cross-Sectional Comparative Study - Cureus
Custom Nightguards Initiated in Dentrix Now Available from Henry Schein - Dentistry Today
DENTSPLY SIRONA Inc. $XRAY Shares Sold by Quantbot Technologies LP - MarketBeat
Landmark study underscores efficacy of Reciproc endodontic system - Dental Tribune US
How dovish Fed policy supports DENTSPLY SIRONA Inc. (DY2) stock2025 Volatility Report & Daily Profit Maximizing Tips - Newser
Will DENTSPLY SIRONA Inc. (DY2) stock maintain strong growthMarket Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Why DENTSPLY SIRONA Inc. (DY2) stock is a strong analyst pickMarket Risk Summary & Growth Focused Investment Plans - Newser
Intraoral Scanners Market Is Going to Boom | Align Technology • - openPR.com
South Korea Dental Anesthesia Market Toward USD 80.5 Billion - openPR.com
Evercore ISI Group Maintains DENTSPLY SIRONA (XRAY) In-Line Recommendation - MSN
Can DENTSPLY SIRONA Inc. stock deliver sustainable ROE2025 Momentum Check & Smart Swing Trading Techniques - Newser
DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts - Yahoo Finance
Dentsply Sirona: Advancing Endodontics through Evidence, Quality, and Innovation - marketscreener.com
Why DENTSPLY SIRONA Inc. (DY2) stock could outperform next yearPortfolio Return Report & Long-Term Safe Investment Ideas - Newser
Manufacturer signs lease renewal in Waltham through 2032 - The Business Journals
Brandes Investment Partners LP Has $5.98 Million Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona Q3 2025 Earnings Preview - MSN
Can Dentsply Sirona Stock Recover If Markets Fall? - Trefis
Why DENTSPLY SIRONA Inc. stock remains resilientDollar Strength & Free Real-Time Market Sentiment Alerts - Newser
U.S. Dental Equipment Market Projections 2025-2032: Key - openPR.com
Is DENTSPLY SIRONA Inc. (DY2) stock considered safe haven2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser
Dentsply Sirona Renews Full-Building Lease in Waltham - Connect CRE
VP Johnson Surrenders 9,030 Of Dentsply Sirona Inc [XRAY] - TradingView
DENTSPLY SIRONA Named Top Dividend Stock With Insider Buying and 5.64% Yield (XRAY) - Nasdaq
Dental Caries Detectors Market Set for Dynamic Growth with Key Players Dentsply Sirona, KaVo Kerr, 3M Company - EIN News
Rotary Niti Endodontic Files Market Is Booming So Rapidly: Dentsply Sirona • Mani Inc. • Komet Dental • VDW GmbH - openPR.com
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
With Dentsply Sirona Stock Sliding, Have You Assessed The Risk? - Trefis
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & G - The National Law Review
Dentsply Sirona Inc Azioni (XRAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.98%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):